August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug JENTADUETO Posted in: Uncategorized
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent expiration for Boehringer Ingelheim drug J…
August 12, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug TRADJENTA Posted in: Uncategorized
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…
The post New patent expiration for Boehringer Ingelheim drug TRADJE…
